IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic Leukemia

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Iacobucci, Ilaria ^a   Iraci, Nunzio ^b,h   Messina, Monica ^c   Lonetti, Annalisa ^b   Chiaretti, Sabina ^c   Valli, Emanuele ^b   Ferrari, Anna ^a   Papayannidis, Cristina ^a   Paoloni, Francesca ^d   Vitale, Antonella ^c   Storlazzi, Clelia Tiziana ^e   Ottaviani, Emanuela ^a   Guadagnuolo, Viviana ^a   Durante, Sandra ^a   Vignetti, Marco ^d   Soverini, Simona ^a   Pane, Fabrizio ^f   Foà, Robin ^c   Baccarani, Michele ^a   Müschen, Markus ^g   Perini, Giovanni ^b   Martinelli, Giovanni ^a   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d GIMEMA Foundation   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUB3 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2C; IKAROS TRANSCRIPTION FACTOR; JANUS KINASE; PROTEIN MCL 1; PROTEIN MSH2; STAT PROTEIN; TRANSCRIPTION FACTOR ETV6;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLK GENE; BUB3 GENE; CDKN1A GENE; CDKN2C GENE; CELL LINEAGE; CELL RENEWAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EBF1 GENE; ETV6 GENE; FEMALE; GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IGLL1 GENE; IKZF1 GENE; JAK GENE; MAJOR CLINICAL STUDY; MALE; MCL1 GENE; MOLECULAR PATHOLOGY; MSH2 GENE; MUTATOR GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STAT GENE; YES1 GENE;

ADOLESCENT; ADULT; AGED; CELL LINE, TUMOR; COHORT STUDIES; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IKAROS TRANSCRIPTION FACTOR; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SIGNAL TRANSDUCTION;

EID: 84864368299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040934     Document Type: Article

References (43)

1. Armstrong SA, Look AT, (2005) Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 23: 6306-6315.
2. Gleissner B, Thiel E, (2003) Molecular genetic events in adult acute lymphoblastic leukemia. Expert Rev Mol Diagn 3: 339-355.
3. Pui CH, Relling MV, Downing JR, (2004) Acute lymphoblastic leukemia. N Engl J Med 350: 1535-1548.
4. Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, et al. (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109: 3189-3197.
5. Bungaro S, Dell'Orto MC, Zangrando A, Basso D, Gorletta T, et al. (2009) Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer 48: 22-38.
6. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764.
7. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, et al. (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453: 110-114.
8. Kawamata N, Ogawa S, Zimmermann M, Kato M, Sanada M, et al. (2008) Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111: 776-784.
9. Mullighan CG, Downing JR, (2009) Global genomic characterization of acute lymphoblastic leukemia. Semin Hematol 46: 3-15.
10. Kawamata N, Ogawa S, Zimmermann M, Niebuhr B, Stocking C, et al. (2008) Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc Natl Acad Sci U S A 105: 11921-11926.
11. Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, et al. (2009) Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 114: 2159-2167.
12. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, et al. (1994) The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143-156.
13. Winandy S, Wu P, Georgopoulos K, (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
14. Georgopoulos K, (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2: 162-174.
15. Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, et al. (2010) IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 24: 1258-1264.
16. Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, et al. (2009) IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 27: 5202-5207.
17. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, et al. (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360: 470-480.
18. Reynaud D, Demarco IA, Reddy KL, Schjerven H, Bertolino E, et al. (2008) Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol 9: 927-936.
19. Kano G, Morimoto A, Takanashi M, Hibi S, Sugimoto T, et al. (2008) Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels. Leuk Lymphoma 49: 965-973.
20. Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, et al. (2009) JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 106: 9414-9418.
21. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM, (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
22. Molnar A, Georgopoulos K, (1994) The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14: 8292-8303.
23. Klug CA, Morrison SJ, Masek M, Hahm K, Smale ST, et al. (1998) Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc Natl Acad Sci U S A 95: 657-662.
24. Nichogiannopoulou A, Trevisan M, Friedrich C, Georgopoulos K, (1998) Ikaros in hemopoietic lineage determination and homeostasis. Semin Immunol 10: 119-125.
25. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, et al. (1996) Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549.
26. Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K, (1999) Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med 190: 1201-1214.
27. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, et al. (2007) High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21: 1258-1266.
28. Copland M, (2009) Ikaros deletions are associated with poor prognosis in acute lymphoblastic leukemia. Future Oncol 5: 455-458.
29. Ng SY, Yoshida T, Zhang J, Georgopoulos K, (2009) Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30: 493-507.
30. Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, et al. (2009) A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol 10: 125-134.
31. Pongubala JM, Northrup DL, Lancki DW, Medina KL, Treiber T, et al. (2008) Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol 9: 203-215.
32. Reese JS, Liu L, Gerson SL, (2003) Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 102: 1626-1633.
33. Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, et al. (2009) Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457: 51-56.
34. Papathanasiou P, Attema JL, Karsunky H, Hosen N, Sontani Y, et al. (2009) Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros. Stem Cells 27: 3082-3092.
35. Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, et al. (2009) Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 206: 1739-1753.
36. Waanders E, van der Velden VH, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, et al. (2010) Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia.
37. Beldjord K, Macintyre E, Lhéritier V, Boulland ML, Leguay T, et al. (2011) Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia- A GRAALL Study. Blood (ASH Annual Meeting Abstracts) 118: 572.
38. Iacobucci I, Lonetti A, Paoloni F, Papayannidis C, Ferrari A, et al. (2010) The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party. Haematologica 95: 1683-1690.
39. Tavolaro S, Chiaretti S, Messina M, Peragine N, Del Giudice I, et al. (2010) Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors. Leuk Res 34: 733-741.
40. Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, et al. (2010) Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 28: 2529-2537.
41. Li C, Wong WH, (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36.
42. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
43. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, et al. (2008) Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A 105: 16224-16229.